Skip to content

A prospective multicentral study for establishing and validate a predictive model for vascular calcification in patients with chronic kidney disease (CKD 1-3)

A prospective multicentral study for establishing and validate a predictive model for vascular calcification in patients with chronic kidney disease (CKD 1-3)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020925
Enrollment
Unknown
Registered
2019-01-22
Start date
2019-02-15
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Case series:Nil

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent; 2. According to the diagnostic criteria of chronic kidney disease, eGFR were calculated according to 2009 CKD-EPI equation, 30ml/min/1.73m2 = eGFR <60ml/min/1.73m2 or eGFR = 60ml/min/1.73m2 and proteinuria (24h urinary protein =0.5g, ACR=30mg/g) or glomerular hematuria or confirmed renal damage by pathological and imaging findings; 3. Aged 18 to 70 years old.

Exclusion criteria

Exclusion criteria: (1) Combined with malignant tumors; (2) Suffering from dementia, mental abnormality or any mental illness that interferes with the understanding of the informed consent; (3) Severe liver dysfunction, child-pugh grade C; (4) Severe cardiac insufficiency, cardiac function level III or above; (5) Acute myocardial infarction existed in the past 3 months; (6) Patients with primary hyperparathyroidism; (7) Previous history of severe atherosclerotic plaque; (8) Perform major surgery within 12 weeks before screening or have not fully recovered from surgery; (9) During the experiment, the imaging examination could not be completed due to pregnancy or illness, and the number of shedding was more than 2 times; (10) Poor compliance, no commitment to complete the follow-up; (11) Participated in cardiovascular related clinical studies within 1 month.

Design outcomes

Primary

MeasureTime frame
AACs;CACs;

Countries

China

Contacts

Public ContactYing Tang

Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

ty.102@163.com+86 020 34071007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026